Gopish Pharma Limited
About Gopish Pharma Limited
Data last updated:
Gopish Pharma Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 April 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PLC067545. Its GSTIN is 07AABCG6958R1ZR (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹68 Lakh. It was formerly known as Gopish Pharma P Limited. It is led by directors including Santosh Goel and Ratish Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H 1455 Dsidc Industrial Complex Narela, Delhi, India – 110040.
As per the financials filed for FY 2025, the company reported a revenue of ₹25,000, a decline of 26% compared to the previous year. For the same year it recorded a net loss of ₹10.93 Lakh and EBITDA of ₹15,230 (EBITDA margin 60.9%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 60% over five years.
As per MCA filings, the company has open charges of ₹13.08 Cr on record. Court records list 70 cases involving the company, including 2 filed by the company and 68 filed against it; 12 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH 1455 Dsidc Industrial Complex Narela, Delhi, India – 110040
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity
The main business activity of Gopish Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Gopish Pharma Limited
FY 2025 filings availableGopish Pharma Limited reported revenue of ₹25,000 (down 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 60% over five years, including a 26% fall in the latest year. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹15,230 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | -₹10.93 Lakh | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 60.9% | |
| Net Profit Margin | •••• | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gopish Pharma are in the company report.
: available in the company report
Board of Directors of Gopish Pharma Limited
Gopish Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Goel | Director | 06 Sep 1995 | 31 Years 1 Months | Current |
| Ratish Goyal Also directs: Rallis Healthcare Private Limited | Director | 01 Jun 2008 | 18 Years 4 Months | Current |
| Ravi Parkash Goel Also directs: Rallis Healthcare Private Limited | Director | 06 Sep 1995 | 31 Years 1 Months | Current |
Auditor Details
Gopish Pharma Limited is audited by ASHOK AGGARWAL & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ASHOK AGGARWAL & CO | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Aug 2011 | State Bank of Bikaner & Jaipur | ₹83 Lakh | Open |
| 25 Jun 2011 | State Bank of Bikaner & Jaipur | ₹7 Lakh | Open |
| 25 Nov 2006 | State Bank of Bikaner & Jaipur | ₹12.18 Cr | Open |
Total charge records: 3 View all charges
Legal Cases
Gopish Pharma Limited has 70 court cases on record: 2 filed by Gopish Pharma, 68 filed against it. 12 cases are pending and 58 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 66 | 65 | 12 |
| High courts | 3 | 2 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 70)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Amritsar, Punjab | Cheque dishonour complaint | Filed against the company by Goliath Exim Private Limited | Disposed |
| District court, Amritsar, Punjab | Criminal miscellaneous application | Filed against the company by Goliath Exim Private Limited | Disposed |
| District court, Amritsar, Punjab | Bail application | Filed against the company by Goliath Exim Private Limited | Disposed |
| District court, North West, Delhi | Criminal case | Filed against the company by M/S Modern Laminators Pvt. Ltd. | Disposed |
| District court, Jhajjar, Haryana | Appeal | Filed by the company against M/S Pendo Plast Pvt. Ltd. Through Kapil Dev | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Gopish Pharma.
: available in the company report
Recent Activity
Gopish Pharma Limited has 5 board changes on record since 1995: 3 appointments and 2 cessations. The latest: Parveen Kumar ceased to be Director on 30 Sep 2009.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Gopish Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCG6958R1ZR | Delhi | Active | 01 Jul 2017 |
| 02AABCG6958R1Z1 | Himachal Pradesh | Active | 01 Jul 2017 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Gopish Pharma is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 April 1995 (31+ years old) and is registered under CIN U74899DL1995PLC067545.
Gopish Pharma has 3 current directors:
- Santosh Goel - Director
- Ratish Goyal - Director
- Ravi Parkash Goel - Director
The latest financial statements of Gopish Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gopish Pharma is 07AABCG6958R1ZR, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AABCG6958R1Z1 (Himachal Pradesh).
The CIN (Corporate Identification Number) of Gopish Pharma is U74899DL1995PLC067545. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gopish Pharma has 70 court cases on record: 2 filed by the company and 68 filed against it. 12 are pending. Most are in the district courts.
Gopish Pharma was incorporated on 20 April 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
Parveen Kumar ceased to be Director on 30 Sep 2009. Ratish Goyal was appointed as Director on 01 Jun 2008. Ratish Goyal ceased to be Director on 08 May 2008. Gopish Pharma has 5 board changes on record in total.
The registered office of Gopish Pharma is at H 1455 Dsidc Industrial Complex Narela, Delhi, India – 110040.
Gopish Pharma operates in the pharma industry, in the drug formulation and development segment.